Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta(1-42) infused rat model

Elibol B. , Beker M. , Terzioglu-Usak S. , Dalli T., Kilic U.

PHYTOMEDICINE, cilt.79, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 79
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.phymed.2020.153324


Background: Thymoquinone (TQ), a biologically active ingredient of Nigella sativa, has anti-inflammatory, antioxidative and neuroprotective properties. Therefore, it could be a good candidate in the recovery of Alzheimer's disease (AD) pathology rather than current symptomatic reliefs.